![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 22, 2020 11:24:19 PM
https://new.mta.info/document/21261
Borrowed from Yahoo
Colleagues,
Your hard work and dedication to keeping the New York region moving throughout this pandemic have been unmatched. We want to assure you that our top priority continues to be your health and safety.
That’s why the MTA is announcing a new voluntary, on-site COVID-19 Screening Program at no cost to employees. As part of MTA’s COVID response protocols and as health experts continue to warn of a second wave, this new on-site screening effort will serve as an additional precautionary measure designed to monitor the health of essential employees, help stop the spread of the virus and maintain a safe work environment.
The initial phase of the new program will launch on Monday, October 26th and include a three-pronged testing approach:
1. Field Sites: On-site testing will be made available on a rotating schedule at select employee facilities. These locations will be determined by MTA Occupational Health Services (OHS) in coordination with operating agencies, prioritizing the hotspot and cluster zone changes made by New York State.
2. Medical Assessment Centers (MACs) and Occupational Health Services (OHS) Facilities: Testing will also be offered to all employees scheduled to visit a MAC or OHS facility. Employees must register to come into a MAC or OHS facility if you are not already scheduled to visit.
3. Existing Partnership with Northwell Health: Additionally, free diagnostic testing remains available to MTA workers at Northwell Health-GoHealth Urgent Care centers throughout the New York metropolitan region.
The COVID-19 Screening Program will be expanded to additional sites and scaled up in the coming weeks. Check back here to get an updated schedule of screening locations.
Here’s how the new screening program works: The MTA is partnering with BioReference Laboratories to perform testing. Testing will be conducted as a PCR nasal swab—which is considered the most accurate test available—and will take approximately five minutes. The program is voluntary, but participation is strongly recommended. Turnaround time for results will be 24-48 hours under normal circumstances and employees will receive their results in that timeframe.
The initial sites we plan to roll out in the next two weeks are as follows:
• Flatbush Bus Depot
• East New York Bus Depot
• Ulmer Park Bus Depot
• Jackie Gleason Bus Depot
• Grand Avenue Bus Depot
• College Point Bus Depot
• Jamaica Bus Depot
• JFK Bus Depot
• Queens Village Bus Depot
• Gun Hill Bus Depot
• West Farms Bus Depot
• Charleston Bus Depot
• Medical Assessment Center 1
• Medical Assessment Center 3
• Medical Assessment Center 5
• OHS Graybar Facility (MNR)
• OHS Mineola Facility (LIRR)
• 207th Street Yard
• Coney Island Yard
• Hillside Yard (LIRR)
Reminder: If you are sick, stay home.
The new screening program is targeted at identifying asymptomatic carriers. We continue to have incidents where employees are reporting to work at MTA locations with COVID-19 like symptoms, including high fever and loss of smell and taste. The implications of coming to work while experiencing symptoms are very serious and puts others at risk and violates our healthcare protocols.
Additionally, we encourage you to get your free flu shot this year which you can get at more than 50 select MTA locations and at all MTA MACs, at your own physician, or free of charge at all Walgreens locations in the New York metropolitan area with a voucher.
Please visit the MTA COVID-19 Employee Resources page to learn more information and sign up today, call the COVID-19 Hotline at 646-252-2010, or speak directly with your manager.
Additionally, testing information can also be found at the New York State Department of Health, or by calling the NYS COVID-19 Hotline at 1-888-364-3065.
Together we can work to keep each other safe during this unprecedented public health crisis.
Regards,
Patrick Warren
Chief Safety Officer
Recent OPK News
- OPKO Health to Participate in the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/31/2024 02:48:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:29:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:07:44 PM
- OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 05/03/2024 12:00:00 PM
- Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business • PR Newswire (US) • 03/28/2024 12:00:00 PM
- Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome • GlobeNewswire Inc. • 03/20/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/07/2024 09:02:37 PM
- AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV • GlobeNewswire Inc. • 03/05/2024 01:52:22 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 09:05:23 PM
- NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st • PR Newswire (US) • 02/28/2024 02:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:07:54 PM
- OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
- OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024 • GlobeNewswire Inc. • 02/22/2024 09:05:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/16/2024 09:53:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:07:24 PM
- NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China • PR Newswire (US) • 02/05/2024 01:09:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 08:30:14 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:15:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:00:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:09:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 10:56:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 10:09:07 PM
- OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes • GlobeNewswire Inc. • 01/09/2024 09:05:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 02:10:34 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM